A detailed history of Cross Staff Investments Inc transactions in Danaher Corp stock. As of the latest transaction made, Cross Staff Investments Inc holds 5,594 shares of DHR stock, worth $1.29 Million. This represents 1.24% of its overall portfolio holdings.

Number of Shares
5,594
Previous 5,593 0.02%
Holding current value
$1.29 Million
Previous $1.4 Million 11.31%
% of portfolio
1.24%
Previous 1.19%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$239.25 - $280.76 $239 - $280
1 Added 0.02%
5,594 $1.56 Million
Q2 2024

Aug 06, 2024

BUY
$235.51 - $267.98 $235 - $267
1 Added 0.02%
5,593 $1.4 Million
Q1 2024

May 01, 2024

BUY
$224.58 - $256.19 $224 - $256
1 Added 0.02%
5,592 $1.4 Million
Q4 2023

Feb 02, 2024

SELL
$185.1 - $233.13 $7,033 - $8,858
-38 Reduced 0.68%
5,591 $1.29 Million
Q3 2023

Oct 17, 2023

SELL
$233.08 - $265.59 $11,187 - $12,748
-48 Reduced 0.85%
5,629 $1.4 Million
Q2 2023

Aug 01, 2023

SELL
$224.99 - $256.14 $134,544 - $153,171
-598 Reduced 9.53%
5,677 $1.36 Million
Q1 2023

Apr 25, 2023

BUY
$239.75 - $277.0 $24,454 - $28,254
102 Added 1.65%
6,275 $1.58 Million
Q4 2022

Jan 30, 2023

BUY
$241.42 - $282.29 $482 - $564
2 Added 0.03%
6,173 $1.64 Million
Q3 2022

Oct 21, 2022

SELL
$247.06 - $1507.4 $11,858 - $72,355
-48 Reduced 0.77%
6,171 $1.59 Million
Q2 2022

Oct 21, 2022

BUY
$237.11 - $299.66 $97,689 - $123,459
412 Added 7.09%
6,219 $1.58 Million
Q2 2022

Jul 29, 2022

SELL
$237.11 - $299.66 $97,452 - $123,160
-411 Reduced 6.61%
5,807 $1.58 Million
Q1 2022

Apr 19, 2022

BUY
$257.27 - $315.76 $514 - $631
2 Added 0.03%
6,218 $1.82 Million
Q4 2021

Feb 07, 2022

BUY
$292.08 - $329.01 $1.82 Million - $2.05 Million
6,216 New
6,216 $2.05 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Cross Staff Investments Inc Portfolio

Follow Cross Staff Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cross Staff Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cross Staff Investments Inc with notifications on news.